CEBPB and hepatocellular carcinoma: Another study also revealed that saikosaponin D exerted anti-cancer effect against HCC by suppressing COX-2 via inhibiting p-STAT3/CCAAT enhancer binding protein beta (C/EBPβ) pathway [263].